(EMAILWIRE.COM, April 15, 2012 ) New York, NY -- At the conclusion of each week, VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, examines some news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. Although focusing intently on the biotech and healthcare sectors, due attention is also given to potential market-moving or game-changing companies in a broad variety of markets and industries. The 'Weekly Stock Watch' will also introduce new companies for coverage and identify some stocks that may have entered 'buy territory'.
Last week was one that belonged to the traders, with quite a bit of downwards action in the markets peppered with a couple of big up days, too. Friday's fall, however - when the DOW dropped over one hundred and thirty points - could have set the tone for Monday's open.
In today's age of volatility, quick-breaking news and intense media hype all playing on the markets, we never really know what's coming next until we get there - which makes it a great trading environment, and also allows those who like to hold for the long term to average down on quite a few instances.
Some big players were making news last week and could do so even more during the coming week.
Google (GOOG) announced that the company will initiate a stock split to ensure company control by its founding members, news that sent shares down by four percent on Friday, while excitement over the Facebook (FB) IPO is also growing.
Some of the big banks were slipping towards the end of the week last week, with Bank of America (BAC) and Citi (C) dropping five and three percent, respectively, during Friday's trading. Any continued dip in either of those big boys could provide investors another chance to buy low(er) and trade into any potential rebounds - as has been the story for the banks over the past couple of years since the crash of 2008-09.
Even some of the little guys were making noise, and could continue to do so during the coming week.
Take Implant Sciences (IMSC), for example. This company makes explosives and narcotics-detection devices that fit right into today's global increased security posture whose shares touched the dollar mark before settling back to close the week at ninety one cents. Implant won a key contract to provide security at the Summit of the Americas that took place over the weekend in Cartagena, Colombia, and the news was well received by investors.
It was also well received by US President Barak Obama's Secret Service security team.
Evidently these guys were so comfortable with Implant's ability to provide security that twelve members from the team decided to live it up like they worked for the GSA and ended up getting sent home for inappropriate behavior before the main event even started. Given the party atmosphere of the Cartagena night life, these guys must have really lived it up to reach the point of "inappropriate."
Regardless of the extra curricular events surrounding the conference, the contract win could be considered a big one for Implant Sciences, and many investors believe that there will be a lot more in store for the company and its share price this year.
Two other companies discussed that may have entered 'buy territory' are Dendreon Corp (DNDN) and Human Genome Sciences (HGSI). Both are trading near their 52-week lows but hold some potential for rebound.
Premier Alliance Group (PIMO), and advisory and consulting firm that just completed a key acquisition that thrusts the company in the middle of the energy efficiency and advisory/consulting markets, may be gearing up for significant growth over the coming quarters.
In the key acquisition of GreenHouse, announced last month, Premier was quickly elevated to a leading player in the energy and sustainability consulting/advisory market. This could turn into a particular boon for business, as municipalities, state and federal agencies are all targeting energy efficiency as a way to trim costs and maintain budget predictions. The GreenHouse deal places Premier right in the middle of this emerging service need and has very positive implications on the company's short and mid term potential to realize significant growth. More will be forthcoming regarding this company from VFC's Stock House this week.
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: